FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:1421-1422 November 9, 2000 Number 19 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Hoeper, M. M. PubMed Citation

To the Editor: Hoeper et al. (June 22 issue)¹ reported improved hemodynamics in a group of 24 patients with primary pulmonary hypertension who were treated with aerosolized iloprost for at least one year. In contrast, we studied 18 such patients who were treated with inhaled iloprost for 12 months and found that the 15 patients with hemodynamic follow-up data had no significant changes from base-line values in preinhalation hemodynamics (pulmonary-artery pressure, 61±16 mm Hg; carbon monoxide, 3.0± 2.1 liters per minute; and pulmonary vascular resistance, 1736±656 dyn·sec·cm^–5).² Right atrial pressure even increased from 5.4±4.2 to 8.5±6.1 mm Hg (P<0.05). . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Baker, S. E, Hockman, R. H. (2005). Inhaled Iloprost in Pulmonary Arterial Hypertension. The Annals of Pharmacotherapy 39: 1265-1274 [Abstract] [Full Text]  
• Dembinski, R., Brackhahn, W., Henzler, D., Rott, A., Bensberg, R., Kuhlen, R., Rossaint, R. (2005). Cardiopulmonary effects of iloprost in experimental acute lung injury. Eur Respir J 25: 81-87 [Abstract] [Full Text]  
• Kramm, T., Eberle, B., Krummenauer, F., Guth, S., Oelert, H., Mayer, E. (2003). Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: effects before and after pulmonary thromboendarterectomy. Ann. Thorac. Surg. 76: 711-718 [Abstract] [Full Text]  
• Molina, J, Lucero, E, Luluaga, S, Bellomio, V, Spindler, A, Berman, A (2003). Systemic lupus erythematosus-associated pulmonary hypertension: good outcome following sildenafil therapy. Lupus 12: 321-323 [Abstract]  
• Opitz, C.F, Wensel, R, Bettmann, M, Schaffarczyk, R, Linscheid, M, Hetzer, R, Ewert, R (2003). Assessment of the vasodilator response in primary pulmonary hypertension: Comparing prostacyclin and iloprost administered by either infusion or inhalation. Eur Heart J 24: 356-365 [Abstract] [Full Text]  
• Evans, T W, Gatzoulis, M A, Gibbs, J S R (2002). A National Pulmonary Hypertension Service for England & Wales: an orphan disease is adopted?. Thorax 57: 471-472 [Full Text]